Primary sclerosing cholangitis. by Mitchell, SA, Chapman, R

Review article: the management of primary sclerosing cholangitis. by Mitchell, SA, Chapman, R

The management of primary sclerosing cholangitis. by Mitchell, SA, Chapman, R

Role of interleukin-10 in the pathogenesis of primary sclerosing cholangitis and primary biliary cirrhosis? by Mitchell, SA, Chapman, R, Fleming, K

Decreased interleukin-10 mRNA expression in primary sclerosing cholangitis and primary biliary cirrhosis: A role for IL10 in the pathogenesis? by Mitchell, SA, Fleming, K, Chapman, R

Cytokine profiles in primary sclerosing cholangitis (PSC) and autoimmune liver diseases: Comparing expression in the periphery and the liver. by Mitchell, SA, Fleming, K, Chapman, R

Treatments for chronic myeloid leukemia: a qualitative systematic review by Ferdin, R, Mitchell SA, Batson S, Tumur I

Get full text

Clinician and Patient Reporting of Symptomatic Adverse Events in Cancer Clinical Trials: Using CTCAE and PRO-CTCAE® to Provide Two Distinct and Complementary Perspectives by Minasian LM, O'Mara A, Mitchell SA

Get full text

Alverine citrate (Spasmonal) fails to relieve the symptoms of irritable bowel syndrome: Results of a double blind, randomised placebo controlled trial by Mitchell, SA, Mee, A, Palmer, K, Chapman, R

Alverine citrate fails to relieve the symptoms of irritable bowel syndrome: Results of a double-blind, randomized, placebo-controlled trial by Mitchell, SA, Mee, A, Smith, G, Palmer, K, Chapman, R

Alverine citrate fails to relieve the symptoms of irritable bowel syndrome: results of a double-blind, randomized, placebo-controlled trial. by Mitchell, SA, Mee, A, Smith, G, Palmer, K, Chapman, R

Down regulation of interferon gamma and up regulation of interleukin-10 by ursodeoxycholic acid (UDCA) in primary sclerosing cholangitis (PSC). by Mitchell, SA, Bansi, D, Christie, J, Fleming, K, Chapman, R

Cigarette smoking, appendectomy, and tonsillectomy as risk factors for the development of primary sclerosing cholangitis: a case control study. by Mitchell, SA, Thyssen, M, Orchard, T, Jewell, D, Fleming, K, Chapman, R

A systematic review and mixed treatment comparison of the efficacy of pharmacological treatments for fibromyalgia. by Choy, E, Marshall, D, Gabriel, Z, Mitchell, SA, Gylee, E, Dakin, H

A Systematic Review and Mixed Treatment Comparison of the Efficacy of Pharmacological Treatments for Fibromyalgia by Choy, E, Marshall, D, Gabriel, Z, Mitchell, SA, Gylee, E, Dakin, H

High dose ursodeoxycholic acid (UDCA) in primary sclerosing cholangitis (PSC): Results after two years of a randomised double-blind, placebo-controlled trial. by Mitchell, SA, Bansi, D, Hunt, N, Christie, J, Fleming, K, Chapman, R

Cigarette smoking, appendectomy and tonsillectomy as risk factors for the development of primary sclerosing cholangitis (PSC): A case control study. by Mitchell, SA, Thyssen, M, Mitchell, M, Orchard, T, Jewell, D, Fleming, K, Chapman, R

A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis. by Mitchell, SA, Bansi, D, Hunt, N, Von Bergmann, K, Fleming, K, Chapman, R

Is the 308 polymorphism in the tumor necrosis factor (alpha) (TNF alpha) promoter region a marker of disease susceptibility in European patients with primary sclerosing cholangitis... by Mitchell, SA, Spurkland, A, Boberg, K, Chapman, R, Fleming, K, Schrumpf, E, Cholangit, E

Incidence and outcome of hepatitis C infection in blood product recipients: Experience of the Oxford blood centre within the National HCV Lookback Program. by Christie, J, Dike, A, Mitchell, SA, Kurtz, J, Teo, C, Rosenberg, W, Fleming, K, Chapman, R